Technology

Theravance Biopharma

$18.13
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.24 (+1.34%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TBPH and other stocks, options, and ETFs commission-free!

About TBPH

Theravance Biopharma, Inc. operates as a biopharmaceutical company. It focuses on the discovery, research, development, and commercialization of organ-selective medicines. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands. The listed name for TBPH is Theravance Biopharma, Inc. Ordinary Shares.

CEO
Rick E. Winningham
Employees
316
Headquarters
George Town, George Town
Founded
2013
Market Cap
1.18B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
311.42K
High Today
$18.56
Low Today
$17.81
Open Price
$17.81
Volume
212.15K
52 Week High
$31.54
52 Week Low
$14.48

Collections

TBPH Earnings

-$1.24
-$0.50
$0.24
$0.98
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 22, After Hours

You May Also Like

WY
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure